(Q33255883)

24 July 2017

0 references

1 reference

title

Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method (English)

1 reference

24 July 2017

0 references

1 reference

1 reference

1 reference

Calamita Z

1

1 reference

24 July 2017

Saconato H

series ordinal

2

1 reference

24 July 2017

Pelá AB

series ordinal

3

1 reference

24 July 2017

Atallah AN

series ordinal

4

1 reference

24 July 2017

publication date

1 October 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

61

1 reference

24 July 2017

issue

10

1 reference

24 July 2017

page(s)

1162-1172

1 reference

Immunotherapy in asthma: an updated systematic review

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Allergic rhinitis and its impact on asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Safety of sublingual-swallow immunotherapy in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

A short assessment of sublingual immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Efficacy of sublingual specific immunotherapy in Cupressaceae allergy using an extract of Cupressus arizonica. A double blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Sublingual immunotherapy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

Mechanisms of allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01205.X

10.1111/J.1398-9995.2006.01205.X

21 January 2018

Identifiers

DOI

1 reference

release_sztxvjievna5jcgw4h36kq4szy

24 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sztxvjievna5jcgw4h36kq4szy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference